Cargando…

Relationship Between Serum Biochemical Markers of Myocardial Fibrosis and Diastolic Function at Rest and With Exercise in Hypertrophic Cardiomyopathy

BACKGROUND AND OBJECTIVES: Recent studies have demonstrated the usefulness of biochemical markers of collagen turnover as markers of myocardial fibrosis in various diseases. In this study, we hypothesized that increased collagen markers in patients with hypertrophic cardiomyopathy (HCM) were correla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shim, Chi Young, Ha, Jong-Won, Choi, Eui-Young, Lee, Hyun-Jin, Moon, Sun-Ha, Kim, Jin-Mi, Rim, Se-Joong, Chung, Namsik
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2009
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801459/ https://www.ncbi.nlm.nih.gov/pubmed/20049137 http://dx.doi.org/10.4070/kcj.2009.39.12.519

Ejemplares similares

Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy
por: Chung, Hyemoon, et al.
Publicado: (2021)

Left Atrial Velocity Vector Imaging Can Assess Early Diastolic Dysfunction in Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy
por: Yoon, Se-Jung, et al.
Publicado: (2023)

Associations between Subclinical Myocardial Dysfunction and Premature Fusion of Early and Late Diastolic Filling with Uncertain Cause
por: Kim, Kyu, et al.
Publicado: (2022)

Effects of left atrial function on pulmonary arterial pressure in acute myocardial infarction, hypertrophic and dilated cardiomyopathy
por: Kim, Minjeong, et al.
Publicado: (2022)

Evaluation of diastolic dysfunction in children with hypertrophic cardiomyopathy and its relationship with development of myocardial fibrosis
por: Deraz, Salem Elsayed, et al.
Publicado: (2023)

Prediction of Left Atrial Fibrosis With Speckle Tracking Echocardiography in Mitral Valve Disease: A Comparative Study With Histopathology
por: Her, Ae-Young, et al.
Publicado: (2012)

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
por: He, Yi, et al.
Publicado: (2010)

Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
por: Hussain, Tarique, et al.
Publicado: (2013)

Genetic relevance and determinants of mitral leaflet size in hypertrophic cardiomyopathy
por: Chung, Hyemoon, et al.
Publicado: (2019)

Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction
por: Ellims, Andris H, et al.
Publicado: (2012)

Burden of premature ventricular contractions beyond nonsustained ventricular tachycardia is related to the myocardial extracellular space expansion in patients with hypertrophic‐cardiomyopathy
por: Chung, Hyemoon, et al.
Publicado: (2020)

Left ventricular diastolic gradient in hypertrophic cardiomyopathy()
por: Pacelli, Filomena, et al.
Publicado: (2016)

Relationship between Myocardial Extracellular Space Expansion Estimated with Post-Contrast T1 Mapping MRI and Left Ventricular Remodeling and Neurohormonal Activation in Patients with Dilated Cardiomyopathy
por: Yoon, Ji Hyun, et al.
Publicado: (2015)

Erratum: Relationship between Myocardial Extracellular Space Expansion Estimated with Post-Contrast T1 Mapping MRI and Left Ventricular Remodeling and Neurohormonal Activation in Patients with Dilated Cardiomyopathy
por: Yoon, Ji Hyun, et al.
Publicado: (2015)

Rest perfusion abnormalities in hypertrophic cardiomyopathy: correlation with myocardial fibrosis and risk factors for sudden cardiac death
por: Chiribiri, A., et al.
Publicado: (2015)

T(1) mapping for characterization of myocardial fibrosis in hypertrophic cardiomyopathy
por: Liu, Ying, et al.
Publicado: (2016)

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: What Remains to be Proven?
por: Sara, Leonardo
Publicado: (2019)

Association of NT-proBNP and hs-cTnT with Imaging Markers of Diastolic Dysfunction and Focal Myocardial Fibrosis in Hypertrophic Cardiomyopathy
por: Chevalier, Céleste, et al.
Publicado: (2022)

Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy
por: Chung, Hyemoon, et al.
Publicado: (2021)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
por: Raman, Betty, et al.
Publicado: (2019)

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts
por: Schlittler, Maja, et al.
Publicado: (2023)

Diverse geometric changes related to dynamic left ventricular outflow tract obstruction without overt hypertrophic cardiomyopathy
por: Cha, Jung-Joon, et al.
Publicado: (2014)

Genotype-Related Clinical Characteristics and Myocardial Fibrosis and Their Association with Prognosis in Hypertrophic Cardiomyopathy
por: Kim, Hyung Yoon, et al.
Publicado: (2020)

Different contribution of extent of myocardial injury to left ventricular systolic and diastolic function in early reperfused acute myocardial infarction
por: Chung, Hyemoon, et al.
Publicado: (2014)

Association of Asymmetric Dimethylarginine and Diastolic Dysfunction in Patients with Hypertrophic Cardiomyopathy
por: Cordts, Kathrin, et al.
Publicado: (2019)

Diastolic Paradoxic Jet Flow of the Right Ventricle in Hypertrophic Cardiomyopathy
por: Shirota, Ayumi, et al.
Publicado: (2020)

Prevalence, functional characteristics, and clinical significance of right ventricular involvement in patients with hypertrophic cardiomyopathy
por: Seo, Jiwon, et al.
Publicado: (2020)

Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy
por: Kuusisto, Johanna, et al.
Publicado: (2012)

Ventricular Diastolic Dimension over Maximal Myocardial Thickness is Robust Landmark of Systolic Impairment in Patients with Hypertrophic Cardiomyopathy
por: Boban, Marko, et al.
Publicado: (2018)

Effect of hypertrophy on left ventricular diastolic function in patients with hypertrophic cardiomyopathy
por: CIAMPI, QUIRINO, et al.
Publicado: (2006)

Impact of septal myectomy on diastolic function in patients with obstructive hypertrophic cardiomyopathy
por: Yang, Qiulan, et al.
Publicado: (2021)

Multimodality Imaging in Patients with Hypertrophic Cardiomyopathy and Atrial Fibrillation
por: Chung, Hyemoon, et al.
Publicado: (2023)

Myocardial fibrosis is not associated with reduced quality of life in patients with dilated or hypertrophic cardiomyopathy
por: Khan, Razi, et al.
Publicado: (2011)

In vivo diffusion-weighted MRI detection of myocardial fibrosis in hypertrophic cardiomyopathy patients
por: Nguyen, Christopher T, et al.
Publicado: (2015)

Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy
por: Fang, Lu, et al.
Publicado: (2015)

Examining the impact of inducible ischemia on myocardial fibrosis and exercise capacity in hypertrophic cardiomyopathy
por: Malahfji, Maan, et al.
Publicado: (2020)

Hypertrophic obstructive cardiomyopathy complicated with acute myocardial infarction and diffuse fibrosis: surgery or not?
por: Wang, Yunhong, et al.
Publicado: (2022)

The Association between the Extent of Late Gadolinium Enhancement and Diastolic Dysfunction in Hypertrophic Cardiomyopathy
por: Alis, Deniz, et al.
Publicado: (2021)

Exercise and myocardial injury in hypertrophic cardiomyopathy
por: Cramer, G Etienne, et al.
Publicado: (2020)

Prognostic Implication of Mitral Valve Disease and Its Progression in East Asian Patients With Hypertrophic Cardiomyopathy
por: Kim, Dae‐Young, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3r37u09l4knhlkugf2ef8o5ep1